Comparison of drug adherence rates among patients with seven different medical conditions.
about
Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsyStrategies for improving adherence to antiepileptic drug treatment in patients with epilepsySelf-report measures of medication adherence behavior: recommendations on optimal useHealth-related quality of life in gout: a systematic reviewMedication adherence in gout: a systematic reviewUsing "big data" to capture overall health status: properties and predictive value of a claims-based health risk scoreMedication adherence in the general populationA review of medication adherence in people with epilepsy.Imaging in gout: A review of the recent developments.Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISAImpact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data.Patients' knowledge and beliefs concerning gout and its treatment: a population based study.Treatment approaches and adherence to urate-lowering therapy for patients with gout.The dynamics of chronic gout treatment: medication gaps and return to therapyPrevention of comorbidity and acute attack of gout by uric acid lowering therapyAny link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based studyAdherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.Importance of including early nonadherence in estimations of medication adherence.Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorderFactors associated with adherence to glaucoma pharmacotherapy in the primary care settingMedication adherence and use of generic drug therapies.Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.2011 recommendations for the diagnosis and management of gout and hyperuricemia.Genome-wide association study of medication adherence in chronic diseases in the korean population.How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularityPlacebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).Psychometric evaluation of a self-medication assessment tool in an elderly populationEffectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data.Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.Effects of Physician Communication and Family Hardiness on Patient Medication Regimen Beliefs and Adherence.Patients and providers view gout differently: a qualitative study.Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic VeteransExtent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans.Rising burden of gout in the UK but continuing suboptimal management: a nationwide population studyObedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients.Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders
P2860
Q24234637-39147B52-BBFA-4AAB-9D28-E9CE31010449Q24241236-EBD4E431-7F5A-4C7F-B2AB-4DC277E42D53Q26775742-7CC7F1F3-672D-45F0-9EA8-93888FA741FCQ27690739-0716969D-467B-42B4-B6AD-9DC79A7BD9B1Q27694691-6EEAB90A-6A86-4B9E-8345-9875C39BE240Q28393538-EA620AF8-2DE7-435D-AC5A-EE24ED3290B0Q28484426-28547C20-8B17-4518-8877-8231D769BE97Q30244080-F3C2C169-D7E2-45BF-9A54-01F2D5C04321Q30427923-FFF9A989-863E-4F17-B607-835B9AEE3691Q30988951-2FCC6270-BA6F-4143-B451-5C1EC4A0E484Q30994474-8A92DCB9-079D-498B-B7D9-26FDF15BA43BQ31096665-143A3F0D-0502-4837-8E06-237BE25EB726Q33597442-B16AD04D-5AE1-49DF-829B-605F636F42CAQ33617747-3402B14F-9344-41BF-923E-E211D6B89B9EQ33627488-060AA64C-6976-4893-837E-868D5258491EQ33655400-87AB14DF-12B6-44B9-B5C3-91140B911D63Q33658763-B4ED00B7-4A50-4268-94F0-75CACCC664EBQ33841204-8582DC39-56F4-4D89-B00A-8E6DB0784645Q33852705-3DBD91B9-C801-42B3-B5A9-308CF9E92F24Q33865315-48D3431D-13B1-4C4E-B637-01D1C37D8585Q33931543-15EBA331-62E4-470F-97C6-E8369DE201CCQ34052798-21CEE089-2FA3-4117-B883-9D65457045E5Q34084953-538DF80E-A050-4C4B-856C-02B45C59CCD2Q34204854-4041C9DC-65C4-4857-86AF-25CFCAA88A25Q34250995-A194E624-6A21-4C0D-83DC-9A72B8D9C1DDQ34335425-ED87D0A8-291D-4EC8-B057-C6F8D7D19CA2Q34344393-327B6DEE-B449-4F31-9727-3A609B221ACAQ34433880-BE220F6A-148B-41C1-825F-A6747D80C9ACQ34441060-48352235-3647-450C-A5A7-FC841027B3BBQ34516192-0A5E75FF-411C-4758-8E84-9ADBA6029218Q34646091-751C7469-7299-458B-86D9-4CD6DB2FBB48Q34726395-ED87BFAD-1003-4E2D-8D96-2B9B6CC017A0Q34774658-3FD03FF9-4D58-4C9B-BCEE-E9347B26A602Q34938270-8AEF6B5B-D6C5-4D79-8097-4B99ABAE53EEQ35099038-4D8EF4EE-4E2F-4D5C-B8EE-E20EAE0A8503Q35113964-74EAB1D9-9134-4B31-901B-32623AD6FE03Q35136139-13A3A9AF-8FE4-430F-B997-CBA90E81FC29Q35352449-CFC882C4-33D5-46A4-94C8-94C133D8ABE8Q35555613-BFE56FA2-1F7C-4D73-8724-C6DA97364F0DQ35649045-625B4E03-5DA2-49B7-B1D8-E21BE28BF189
P2860
Comparison of drug adherence rates among patients with seven different medical conditions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of drug adherence r ...... different medical conditions.
@en
Comparison of drug adherence r ...... different medical conditions.
@nl
type
label
Comparison of drug adherence r ...... different medical conditions.
@en
Comparison of drug adherence r ...... different medical conditions.
@nl
prefLabel
Comparison of drug adherence r ...... different medical conditions.
@en
Comparison of drug adherence r ...... different medical conditions.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of drug adherence rates among patients with seven different medical conditions
@en
P2093
Becky A Briesacher
Hassan Fouayzi
Susan E Andrade
P2860
P304
P356
10.1592/PHCO.28.4.437
P407
P50
P577
2008-04-01T00:00:00Z